CELLE, GUIDO
 Distribuzione geografica
Continente #
EU - Europa 6.176
AS - Asia 206
SA - Sud America 31
NA - Nord America 16
AF - Africa 3
Totale 6.432
Nazione #
IT - Italia 6.174
SG - Singapore 75
CN - Cina 71
VN - Vietnam 47
BR - Brasile 24
US - Stati Uniti d'America 8
HK - Hong Kong 5
MX - Messico 5
AR - Argentina 4
BD - Bangladesh 4
CA - Canada 2
EC - Ecuador 2
IQ - Iraq 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
JP - Giappone 1
KE - Kenya 1
TN - Tunisia 1
UY - Uruguay 1
Totale 6.432
Città #
Genova 3.977
Genoa 1.298
Rapallo 530
Vado Ligure 367
Beijing 30
Singapore 23
Ho Chi Minh City 18
Hanoi 9
Hong Kong 5
Mexico City 5
Da Nang 3
Ashburn 2
Haiphong 2
Ninh Bình 2
Porto Alegre 2
Quito 2
Rome 2
Andradina 1
Atibaia 1
Baghdad 1
Baoding 1
Ben Arous 1
Britânia 1
Bắc Giang 1
Can Tho 1
Chapecó 1
Dhaka 1
Fantino 1
Florianópolis 1
Formosa 1
Guangzhou 1
Hải Dương 1
Irecê 1
Isidro Casanova 1
Itabirito 1
Itaguaí 1
Ituzaingó 1
João Pessoa 1
Los Angeles 1
Minsk 1
Montevideo 1
Montreal 1
Nairobi 1
Nha Trang 1
Niterói 1
Oklahoma City 1
Orem 1
Ourinhos 1
Palhoça 1
Phú Thọ 1
Pirapozinho 1
Porto Velho 1
Quảng Ngãi 1
Recife 1
Redenção 1
Rio de Janeiro 1
Salvador 1
San Juan Bautista 1
Shijiazhuang 1
Sofia 1
Sorocaba 1
Suzano 1
São Joaquim de Bicas 1
São Paulo 1
Tanta 1
Thái Nguyên 1
Tokyo 1
Tây Ninh 1
Vinh 1
Totale 6.329
Nome #
Hepatitis G virus infection in haemodialysis and in peritoneal dialysis patients. 206
Time pattern of gastric acidity in Barrett's esophagus 191
Circadian monitoring of gastric juice mutagenicity. 181
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. 176
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. 163
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? 161
Acid and gastric metaplasia in the duodenum 156
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. 155
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. 155
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. 154
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. 150
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. 148
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. 147
Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer. 145
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. 144
Anti-helicobacter regimens 143
24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring. 136
COMPARATIVE EFFECTS OF CHEENODEOXYCHOLIC (CDCA) AND URSODEOXYCHOLIC ACID (UDCA) IN PREGNAT RATS. 135
Interferon retreatment in chronic hepatitis C: wich patients to choose, and what schedule to use 134
Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment. 134
Helicobacter pylori eradication and reinfection 125
Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. 122
Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. 121
The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients. 121
Failure of new diagnostic aids in improving detection of pancreatic cancer at a resectable stage. 120
Helicobacter pylori eradication in long-term users of non-steroidal anti-inflammatory drugs 118
Gastric metaplasia and Helicobacter pylori infection. 116
Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease? 115
Chenodeoxycholic acid (CDCA) versus ursodeoxycholic (UDCA): a comparison of their effects in pregnant rats. 115
Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer. 114
Analysis of circadian fluctuations of bile salt concentration and pH in the stomach of normal subjects and patients suspected of having duodenogastric reflux. 114
Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition? 113
Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection. 109
Circadian acidity pattern in gastric ulcers at different sites. 108
Duodenal ulcer resistant to usual omeprazole dose. 105
Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection. 105
Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. 104
Bolus infusion of famotidine: effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients. 102
Pharmacodynamics of famotidine in gastric ulcer. 101
Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test. 101
Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori. 101
Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring. 99
Ulcer heterogeneity: further arguments for a range of antisecretory treatment. 99
Duration of acid suppression in H2-antagonist nonresponders. 97
Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg. 94
Acid inhibition and amoxicillin activity against Helicobacter pylori. 93
Lack of gastric acid rebound after stopping a successful short-term course of nizatidine in duodenal ulcer patients. 92
Helicobacter pylori and NSAID-induced ulcers. 92
Once or twice daily doses of proton pump inhibitor in treating Barrett's esophagus? 91
Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study. 78
Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy. 77
Effect of one-month treatment with nonsteroidal antiinflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients. 56
Totale 6.432
Categoria #
all - tutte 19.203
article - articoli 15.404
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 3.799
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021169 0 0 0 0 0 15 19 22 38 40 15 20
2021/2022554 20 47 32 86 11 45 55 93 22 61 18 64
2022/2023638 68 47 8 58 122 100 0 40 106 5 76 8
2023/2024261 9 29 6 28 18 40 7 17 28 3 28 48
2024/2025891 43 74 25 42 123 96 72 149 31 34 103 99
2025/2026665 204 26 81 163 168 23 0 0 0 0 0 0
Totale 6.432